Fiasp and Necitumumab Intravenous
Determining the interaction of Fiasp and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Fiasp Injection
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fiasp-Necon
- Fiasp-Necon 0.5/35
- Fiasp-Necon 1/35
- Fiasp-Necon 1/50
- Fiasp-Necon 1/50 (28)
- Fiasp-Necon 7/7/7
- Necitumumab Intravenous-Fiasp (Insulin Aspart (Cartridges & Prefilled Pens) (Fiasp))
- Necitumumab Intravenous-Fiasp (Insulin Aspart (Vials) (Fiasp))
- Necitumumab Intravenous-Fiasp (Insulin Aspart (Vials))
- Necitumumab Intravenous-Fiasp FlexTouch
- Necitumumab Intravenous-Fiasp Injection
- Necitumumab Intravenous-Fiber Lax